What one share of BioLife Solutions holds
We are a life sciences company that develops, manufactures, and markets bioproduction products and services which are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry.
BioLife Solutions’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.21 |
|---|---|
| Profit | $1.20 |
| Capex (buildings and equipment) | $0.18 |
| Free cash flow | $0.17 |
| Cash and investments | $0.49 |
| Debt | $0.00 |
| Book value | $8.59 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $0.04 | −$0.03 | $0.00 | −$0.02 | — | −$0.16 |
| 2012 | $1.14 | −$0.33 | $0.23 | −$0.06 | — | −$2.51 |
| 2013 | $1.79 | −$0.22 | $0.05 | −$0.02 | — | −$2.64 |
| 2014 | $0.59 | −$0.31 | $0.06 | −$0.36 | — | $1.15 |
| 2015 | $0.53 | −$0.35 | $0.01 | −$0.42 | — | $0.68 |
| 2016 | $0.65 | −$0.54 | $0.01 | −$0.35 | — | $0.25 |
| 2017 | $0.83 | −$0.21 | $0.01 | $0.03 | — | −$0.68 |
| 2019 | $1.41 | −$0.09 | $0.03 | $0.03 | — | $2.08 |
| 2020 | $1.76 | −$0.06 | $0.07 | $0.17 | — | $6.19 |
| 2021 | $3.09 | −$0.23 | $0.22 | −$0.34 | — | $11.43 |
| 2022 | $1.77 | −$3.25 | $0.24 | −$0.44 | — | $8.50 |
| 2023 | $1.56 | −$1.56 | $0.15 | −$0.43 | — | $7.48 |
| 2024 | $1.62 | −$0.44 | $0.07 | $0.11 | — | $7.44 |
| 2025 | $1.98 | −$0.10 | $0.19 | $0.22 | — | $7.72 |
Common questions about BioLife Solutions
How much does one share of BioLife Solutions earn?
Over the last 12 months, each share of BioLife Solutions earned $1.20 of profit on $2.21 of sales, keeping about 54¢ of every $1 (profit margin).
Does BioLife Solutions pay a dividend?
BioLife Solutions didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is BioLife Solutions’s book value per share?
BioLife Solutions’s book value is $8.59 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of BioLife Solutions have?
Each share of BioLife Solutions has $0.49 of cash and investments and $0.00 of debt, as of June 30, 2026.
What is BioLife Solutions’s free cash flow per share?
$0.17 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has BioLife Solutions bought back shares?
BioLife Solutions’s share count fell about 30% from 2011 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.